Literature DB >> 27671021

Which unscheduled return visits indicate a quality-of-care issue?

Alberto Jiménez-Puente1,2, José Del Río-Mata3, José Luís Arjona-Huertas4, Begoña Mora-Ordóñez5, Alfonso Martínez-Reina3, Miguel Martínez Del Campo4, Lourdes Nieto-de Haro5, Antonio Lara-Blanquer6.   

Abstract

BACKGROUND: The rate of unscheduled return visits is often used as a quality-of-care indicator in EDs, although its validity is not yet fully established. Our aim was to identify the characteristics of return visits that may be attributed to problems in quality of care.
METHODS: Retrospective paired review of medical charts in a random sample of return visits during the 72 hours following discharge from the ED in three hospitals of Andalusia, Spain in 2013. Charts were reviewed by senior medical physicians to determine which return visits reflected quality-of-care problems. Time frame for return visit, index and return visit acuity, disposition and diagnosis were compared with determine which variables were associated with a quality problem. Sensitivity and specificity for each variable to indicate a quality problem were determined.
RESULTS: We studied the causes of 895 return visits, finding that 65 (7.3%) were due to inadequate quality of care in the index visit. Potentially avoidable return visits were more common in more severely ill patients, in those with greater severity in the return than in the index visit and in patients hospitalised after the return. The combination of this three variables presented sensitivity 66% and specificity 68% in identification of quality-related returns.
CONCLUSIONS: The overall level of return visits cannot be considered a valid indicator of quality of care. However, certain specific variables, including the level of severity of the patient's condition or the discharge destination following the return visits, could be considered valid in this respect. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  emergency department utilisation; quality assurance; research, epidemiology

Mesh:

Year:  2016        PMID: 27671021     DOI: 10.1136/emermed-2015-205603

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  7 in total

1.  Patterns in emergency department unscheduled return visits during the COVID-19 pandemic.

Authors:  Garrett S Thompson; Robert P Olympia
Journal:  Am J Emerg Med       Date:  2022-05-20       Impact factor: 4.093

2.  Inpatient Outcomes Following a Return Visit to the Emergency Department: A Nationwide Cohort Study.

Authors:  Chu-Lin Tsai; Dean-An Ling; Tsung-Chien Lu; Jasper Chia-Cheng Lin; Chien-Hua Huang; Cheng-Chung Fang
Journal:  West J Emerg Med       Date:  2021-08-30

3.  Prevalence, Reasons, and Predisposing Factors Associated with 30-day Hospital Readmissions in Poland.

Authors:  Jacek Kryś; Błażej Łyszczarz; Zofia Wyszkowska; Kornelia Kędziora-Kornatowska
Journal:  Int J Environ Res Public Health       Date:  2019-07-02       Impact factor: 3.390

4.  Risk factors of admission in 72-h return visits to emergency department.

Authors:  Sung-Wei Liu
Journal:  Tzu Chi Med J       Date:  2020-12-24

5.  Qualitative evaluation of a mandatory provincial programme auditing emergency department return visits.

Authors:  Lucas B Chartier; Hanna Jalali; M Bianca Seaton; Howard Ovens; Bjug Borgundvaag; Shelley L McLeod; Katie N Dainty; Olivia Ostrow
Journal:  BMJ Open       Date:  2021-04-07       Impact factor: 2.692

6.  ICU admission following an unscheduled return visit to the pediatric emergency department within 72 hours.

Authors:  Charng-Yen Chiang; Fu-Jen Cheng; Yi-Syun Huang; Yu-Lun Chen; Kuan-Han Wu; I-Min Chiu
Journal:  BMC Pediatr       Date:  2019-08-02       Impact factor: 2.125

7.  Influence of Overcrowding in the Emergency Department on Return Visit within 72 Hours.

Authors:  Dong-Uk Kim; Yoo Seok Park; Joon Min Park; Nathan J Brown; Kevin Chu; Ji Hwan Lee; Ji Hoon Kim; Min Joung Kim
Journal:  J Clin Med       Date:  2020-05-09       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.